Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 49 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
481 18.0 months NHL 5 Biologic therapy
Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 1/2014
Treatment Details: Patients: This phase 2 study involved 37 advanced cutaneous T cell lymphoma patients. The median patient age was 56 years and 54% were male. Treatment: Patients were treated with the c
 
482 18.0 months Recurrent epithelial ovarian cancer and fallopian tube or primary peritoneal cancer 4 Chemotherapy
M.D. Anderson Cancer Center United States 6/2014
Treatment Details: Patients: This phase 2 study involved previously treated, persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma patients who were divided into two separ
 
483 18.0 months Hepatocellular Carcinoma 5 Chemotherapy
Mie University School of Medicine Japan 11/2014
Treatment Details: Patients: This phase 2 study involved 35 hepatocellular carcinoma patients. The average patient age was 74 years and 69% were male. Treatment: Patients received chemotherapy with cispl
 
484 17.9 months Aggressive NHL 4 Chemotherapy
Hormone
Universitat Koln Germany 4/2011
Treatment Details: Patients: This phase II study involved 30 patients with aggressive non-Hodgkin’s lymphoma who had previously received chemotherapy. The median patient age was 61.2 years and 40% were male.
 
485 17.9 months Aggressive non-Hodgkin’s lymphoma 4 Chemotherapy
Hormone
Universität Köln Germany 4/2011
Treatment Details: Patients: This phase II study involved 30 aggressive non-Hodgkin lymphoma patients who had relapsed following previous chemotherapy. The median patient age was 61.2 years and 40% were male
 
486 17.9 months Metastatic breast cancer and locally advanced breast cancer 5 Chemotherapy
Herlev Hospital Denmark 12/2011
Treatment Details: Patients: This phase III study involved women with locally advanced or metastatic breast cancer who were divided into two separate treatment groups. Group A consisted of 170 patients with
 
487 17.9 months Metastatic renal cell carcinoma 4 Chemotherapy
The University of Texas M. D. Anderson Cancer Center United States 9/2008
Treatment Details: Patients: This phase II study involved 83 patients with metastatic renal cell carcinoma (kidney cancer). There were 65 men and 18 women in the study. These patients had received previous
 
488 17.9 months Metastatic colorectal cancer 5 Chemotherapy
UO Oncologia Medica Italy 6/2009
Treatment Details: Patients: This phase 2 study involved 36 patients with unresectable metastatic colorectal cancer. The median age was 65, ranging from 42 to 73 years of age. There were 28 men and 8 women
 
489 17.8 months Platinum refractory or resistant ovarian cancer 4 Chemotherapy
MD Anderson Cancer Center, University of Texas United States 3/2010
Treatment Details: Patients: This phase 2 study involved 39 women with platinum refractory or resistant ovarian cancer. The median age was 54.5 years, with a range of 34.8-75.4. Treatment: Patients recei
 
490 17.8 months Metastatic breast cancer 5 Chemotherapy
Tokai University School of Medicine Japan 11/2010
Treatment Details: Patients: This phase 2 study involved 62 women with metastatic breast cancer who had previously been treated with anthracycline and taxane drugs. The median age of the group was 53 years w
 
Page 49 of 187  | Previous Page  | Next Page